Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Impairments”

694 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 694 results

Early research (Phase 1)Study completedNCT05497297
What this trial is testing

Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 42
Early research (Phase 1)Ended earlyNCT06611423
What this trial is testing

AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Renal Impairment
AstraZeneca 10
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Early research (Phase 1)Active Not RecruitingNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 34
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT05495581
What this trial is testing

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 28
Early research (Phase 1)Ended earlyNCT04426357
What this trial is testing

Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult Participants

Who this might be right for
Renal Impairment
Janssen Pharmaceutica N.V., Belgium 6
Early research (Phase 1)Study completedNCT07076030
What this trial is testing

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Who this might be right for
Renal Impairment
Zealand Pharma 39
Post-approval studies (Phase 4)Study completedNCT01043094
What this trial is testing

Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

Who this might be right for
Severe Renal Impairment
Kowa Research Institute, Inc. 16
Not applicableStudy completedNCT02917057
What this trial is testing

Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 6,024
Testing effectiveness (Phase 2)Study completedNCT02002702
What this trial is testing

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

Who this might be right for
Acute Heart Failure
Novartis Pharmaceuticals 46
Not applicableNot Yet RecruitingNCT07636083
What this trial is testing

Acute Kidney Injury in Upper GI Bleeding Patients

Who this might be right for
Upper Gastrointestinal BleedingAcute Kidney Injury
Sohag University 200
Post-approval studies (Phase 4)Ended earlyNCT05552859
What this trial is testing

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Sanofi 62
Early research (Phase 1)Study completedNCT02696642
What this trial is testing

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Who this might be right for
Neoplasms
Bayer 54
Early research (Phase 1)Study completedNCT00731523
What this trial is testing

Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.

Who this might be right for
Renal Insufficiency
Novartis 18
Not applicableStudy completedNCT00905619
What this trial is testing

Cognitive Impairment in Kidney Disease

Who this might be right for
Kidney Insufficiency, Chronic
VA Office of Research and Development 117
Testing effectiveness (Phase 2)Study completedNCT00706771
What this trial is testing

Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study

Who this might be right for
Systemic Inflammatory Response SyndromeOliguriaRenal Impairment
Austin Health 70
Early research (Phase 1)Study completedNCT05489614
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Amgen 33
Not applicableStudy completedNCT05960006
What this trial is testing

Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

Who this might be right for
Antibiotic ToxicityLiver CirrhosisRenal Insufficiency+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Early research (Phase 1)Study completedNCT00833716
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Renal Impairment
Novo Nordisk A/S 62
Load More Results